4th Quarter - Report

FOLEY HOAG LLP for AMGEN

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

LobbyistCovered position, as disclosed
J KEVIN BRENNAN —
PAUL KIM —
NICK LITTLEFIELD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)

LobbyistCovered position, as disclosed
J KEVIN BRENNAN —
PAUL KIM —
NICK LITTLEFIELD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.